| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23:42 | Hillenbrand declares quarterly dividend of $0.2275 per share | ||
| 23:42 | BKV closes $170.3 million public offering of common stock | ||
| 23:30 | Brady Corporation shareholders elect directors, declare dividend | ||
| 23:30 | Apellis' EMPAVELI shows 68% reduction in proteinuria for rare kidney diseases | ||
| 23:30 | EQB to acquire PC Financial from Loblaw for $800 million | ||
| 23:30 | Franklin Templeton reports $1.67 trillion in assets under management | ||
| 23:30 | Cboe global markets reports record index options trading in November | ||
| 23:30 | ITT appoints Nazzic Keene as next board chair, effective May 2026 | ||
| 23:30 | Cal-Maine Foods expands prepared foods capacity with $22 million investment | ||
| 23:30 | MDU Resources announces $200 million common stock offering | ||
| 23:30 | Stifel initiates coverage on Propel Holdings stock with Buy rating | ||
| 23:18 | Boeing elects former Alaska Air Group CEO Tilden to board | ||
| 23:18 | Tile Shop shareholders approve reverse stock split ahead of delisting | ||
| 23:18 | Medtronic's Hugo robotic surgery system cleared by FDA for urology | ||
| 23:18 | Commerce Bancshares adjusts exchange ratio in FineMark acquisition | ||
| 23:18 | American Eagle Outfitters declares quarterly dividend of $0.125 | ||
| 23:18 | Equinix CFO Keith Taylor to retire in 2026 after 27-year tenure | ||
| 23:18 | Tiptree shareholders approve Fortegra acquisition by DB Insurance | ||
| 23:18 | Skyward Specialty secures regulatory approvals for Apollo acquisition | ||
| 23:18 | Irish court approves XOMA Royalty's acquisition of Mural Oncology | ||
| 23:18 | WTW declares quarterly dividend of $0.92 per share | ||
| 23:18 | NiSource stock price target raised to $50 from $44 at Mizuho on Amazon deal | ||
| 23:18 | Freedom Capital Markets initiates coverage on Paymentus stock with Buy rating | ||
| 23:18 | Mizuho lowers Kodiak Gas Services stock price target to $44 on revised estimates | ||
| 23:18 | Stifel initiates Tango Therapeutics stock with Buy rating, $15 price target |